A multicentre, open-label, observational study of testosterone gel (1%) in the treatment of adult men with hypogonadism.

Trial Profile

A multicentre, open-label, observational study of testosterone gel (1%) in the treatment of adult men with hypogonadism.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2011

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Sponsors Auxilium Pharmaceuticals
  • Most Recent Events

    • 04 Nov 2011 New trial record
    • 03 Nov 2011 Results published in the Journal of Sexual Medicine, according to an Auxilium Pharmaceuticals media release. Results were also presented in the media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top